{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:37:25Z","timestamp":1784590645968,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10787-018-0514-9","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T01:49:36Z","timestamp":1532915376000},"page":"1151-1164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-2043","authenticated-orcid":false,"given":"Neide Tomimura","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0801-3098","authenticated-orcid":false,"given":"Tatiana Mayumi Veiga","family":"Iriyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0217-9329","authenticated-orcid":false,"given":"Daniela Frizon","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-6782","authenticated-orcid":false,"given":"Andr\u00e9a Name Colado","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9127-8264","authenticated-orcid":false,"given":"Isaias","family":"Dichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"514_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/antiox6030051","volume":"6","author":"F Ahmadinejad","year":"2017","unstructured":"Ahmadinejad F, Geir M\u00f8ller S, Hashemzadeh-Chaleshtori M et al (2017) Molecular mechanisms behind free radical scavengers function against oxidative stress. Antioxidants 6:51. \n                    https:\/\/doi.org\/10.3390\/antiox6030051","journal-title":"Antioxidants"},{"key":"514_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.clinbiochem.2006.10.006","volume":"40","author":"O Altindag","year":"2007","unstructured":"Altindag O, Karakoc M, Kocyigit A et al (2007) Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem 40:167\u2013171. \n                    https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.10.006","journal-title":"Clin Biochem"},{"key":"514_CR3","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1186\/ar3424","volume":"13","author":"M Biniecka","year":"2011","unstructured":"Biniecka M, Kennedy A, Ng CT et al (2011) Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther 13:R121. \n                    https:\/\/doi.org\/10.1186\/ar3424","journal-title":"Arthritis Res Ther"},{"key":"514_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1155\/2016\/5698931","volume":"2016","author":"SK Biswas","year":"2016","unstructured":"Biswas SK (2016) Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev 2016:17\u201319. \n                    https:\/\/doi.org\/10.1155\/2016\/5698931","journal-title":"Oxid Med Cell Longev"},{"key":"514_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1201\/b16653-24","volume-title":"Oxidative stress in rheumatoid arthritis. In: Role of oxidative stress in chronic diseases","author":"L Blanco","year":"2014","unstructured":"Blanco L, Ling S, Holoshitz J (2014) Oxidative stress in rheumatoid arthritis. In: Role of oxidative stress in chronic diseases. CRC Press, Boca Raton, pp 481\u2013500"},{"key":"514_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0300060515593227","volume":"44","author":"F Cacciapaglia","year":"2016","unstructured":"Cacciapaglia F, Grazia Anelli M, Rizzo D et al (2016) Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis. J Int Med Res 44:28\u201332. \n                    https:\/\/doi.org\/10.1177\/0300060515593227","journal-title":"J Int Med Res"},{"key":"514_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.fct.2006.12.001","volume":"45","author":"MF Casado","year":"2007","unstructured":"Casado MF, Cecchini AL, Sim\u00e3o ANC et al (2007) Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Food Chem Toxicol 45:945\u2013952. \n                    https:\/\/doi.org\/10.1016\/j.fct.2006.12.001","journal-title":"Food Chem Toxicol"},{"key":"514_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.joca.2003.12.005","volume":"12","author":"IB Coimbra","year":"2004","unstructured":"Coimbra IB, Jimenez SA, Hawkins DF et al (2004) Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes. Osteoarthr Cartil 12:336\u2013345. \n                    https:\/\/doi.org\/10.1016\/j.joca.2003.12.005","journal-title":"Osteoarthr Cartil"},{"key":"514_CR9","doi-asserted-by":"publisher","first-page":"8962763","DOI":"10.1155\/2016\/8962763","volume":"2016","author":"NT Costa","year":"2016","unstructured":"Costa NT, Veiga Iriyoda TM, Kallaur AP et al (2016) Influence of insulin resistance and TNF-alfa on the inflammatory process, oxidative stress, and disease activity in patients with rheumatoid arthritis. Oxid Med Cell Longev 2016:8962763. \n                    https:\/\/doi.org\/10.1155\/2016\/8962763","journal-title":"Oxid Med Cell Longev"},{"key":"514_CR10","first-page":"232","volume":"30","author":"AA Broeder den","year":"2003","unstructured":"den Broeder AA, Wanten GJA, Oyen WJG et al (2003) Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis. J Rheumatol 30:232\u2013237","journal-title":"J Rheumatol"},{"key":"514_CR11","first-page":"959","volume":"14","author":"PB Desai","year":"2010","unstructured":"Desai PB, Manjunath S, Kadi S et al (2010) Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study. Eur Rev Med Pharmacol Sci 14:959\u2013967","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"514_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/ard.62.5.440","volume":"62","author":"O Elkayam","year":"2003","unstructured":"Elkayam O, Yaron I, Shirazi I et al (2003) Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis 62:440\u2013443. \n                    https:\/\/doi.org\/10.1136\/ard.62.5.440","journal-title":"Ann Rheum Dis"},{"key":"514_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000200022","volume":"83","author":"M Feij\u00f3o","year":"2009","unstructured":"Feij\u00f3o M, T\u00fanez I, Tasset I et al (2009) Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases. Pharmacology 83:211\u2013216. \n                    https:\/\/doi.org\/10.1159\/000200022","journal-title":"Pharmacology"},{"key":"514_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/clim.1999.4777","volume":"93","author":"RI Fox","year":"1999","unstructured":"Fox RI, Herrmann ML, Frangou CG et al (1999) Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol 93:198\u2013208. \n                    https:\/\/doi.org\/10.1006\/clim.1999.4777","journal-title":"Clin Immunol"},{"key":"514_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/ars.2015.6317","volume":"23","author":"J Frijhoff","year":"2015","unstructured":"Frijhoff J, Winyard PG, Zarkovic N et al (2015) Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal 23:1144\u20131170. \n                    https:\/\/doi.org\/10.1089\/ars.2015.6317","journal-title":"Antioxid Redox Signal"},{"key":"514_CR16","first-page":"452","volume":"27","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A et al (2009) Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. Clin Exp Rheumatol 27:452\u2013458","journal-title":"Clin Exp Rheumatol"},{"key":"514_CR17","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.4049\/jimmunol.164.4.2170","volume":"164","author":"SI Gringhuis","year":"2000","unstructured":"Gringhuis SI, Leow A, Papendrecht-van der Voort EAM et al (2000) Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol 164:2170\u20132179. \n                    https:\/\/doi.org\/10.4049\/jimmunol.164.4.2170","journal-title":"J Immunol"},{"key":"514_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1756-185X.2011.01630.x","volume":"14","author":"SZ Hassan","year":"2011","unstructured":"Hassan SZ, Gheita TA, Kenawy SA et al (2011) Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 14:325\u2013331. \n                    https:\/\/doi.org\/10.1111\/j.1756-185X.2011.01630.x","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"514_CR19","first-page":"317","volume":"26","author":"S Herman","year":"2008","unstructured":"Herman S, Zurgil N, Langevitz P, Ehrenfeld M, Deutsch M (2008) Methotrexate selectively modulates TH1\/TH2 balance in active rheumatoid arthritis patients. Clin Exp Rheumatol 26(2):317\u2013323","journal-title":"Clin Exp Rheumatol"},{"key":"514_CR20","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1007\/s00296-011-2135-0","volume":"32","author":"M Hirao","year":"2012","unstructured":"Hirao M, Yamasaki N, Oze H et al (2012) Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab. Rheumatol Int 32:4041\u20134045. \n                    https:\/\/doi.org\/10.1007\/s00296-011-2135-0","journal-title":"Rheumatol Int"},{"key":"514_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/ar1447","volume":"6","author":"CA Hitchon","year":"2004","unstructured":"Hitchon CA, El-Gabalawy HS (2004) Oxidation in rheumatoid arthritis. Arthritis Res Ther 6:265\u2013278. \n                    https:\/\/doi.org\/10.1186\/ar1447","journal-title":"Arthritis Res Ther"},{"key":"514_CR22","volume-title":"Rheumatology","author":"M Hochberg","year":"2015","unstructured":"Hochberg M, Silman A, Smolen J et al (2015) Rheumatology, Sixth edn. Elsevier Mosby, Philadelphia","edition":"Sixth"},{"key":"514_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s10165-007-0607-6","volume":"17","author":"Y Kageyama","year":"2007","unstructured":"Kageyama Y, Takahashi M, Nagafusa T et al (2007) Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis. Mod Rheumatol 17:398\u2013402. \n                    https:\/\/doi.org\/10.1007\/s10165-007-0607-6","journal-title":"Mod Rheumatol"},{"key":"514_CR24","first-page":"73","volume":"26","author":"Y Kageyama","year":"2008","unstructured":"Kageyama Y, Takahashi M, Ichikawa T et al (2008a) Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis. Clin Exp Rheumatol 26:73\u201380","journal-title":"Clin Exp Rheumatol"},{"key":"514_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00296-007-0419-1","volume":"28","author":"Y Kageyama","year":"2008","unstructured":"Kageyama Y, Takahashi M, Nagafusa T et al (2008b) Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis. Rheumatol Int 28:245\u2013251. \n                    https:\/\/doi.org\/10.1007\/s00296-007-0419-1","journal-title":"Rheumatol Int"},{"key":"514_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12972","author":"K Kizaki","year":"2016","unstructured":"Kizaki K, Yamashita F, Hayashi T, Funakoshi N (2016) Infliximab is equivalently suppressing oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis. Int J Rheum Dis. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12972","journal-title":"Int J Rheum Dis"},{"key":"514_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cca.2006.04.002","volume":"372","author":"H Lemarechal","year":"2006","unstructured":"Lemarechal H, Allanore Y, Chenevier-Gobeaux C et al (2006) Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta 372:147\u2013153. \n                    https:\/\/doi.org\/10.1016\/j.cca.2006.04.002","journal-title":"Clin Chim Acta"},{"key":"514_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/annrheumdis-2013-204021","volume":"74","author":"J Listing","year":"2015","unstructured":"Listing J, Kekow J, Manger B et al (2015) Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNF\u03b1 inhibitors and rituximab. Ann Rheum Dis 74:415\u2013421. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204021","journal-title":"Ann Rheum Dis"},{"key":"514_CR29","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.27425","volume":"62","author":"E Myasoedova","year":"2010","unstructured":"Myasoedova E, Crowson CS, Kremers HM et al (2010) Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955\u20132007. Arthritis Rheum 62:1576\u20131582. \n                    https:\/\/doi.org\/10.1002\/art.27425","journal-title":"Arthritis Rheum"},{"key":"514_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3109\/14397595.2014.891495","volume":"24","author":"A Nakajima","year":"2014","unstructured":"Nakajima A, Aoki Y, Shibata Y et al (2014) Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis. Mod Rheumatol 24:926\u2013930. \n                    https:\/\/doi.org\/10.3109\/14397595.2014.891495","journal-title":"Mod Rheumatol"},{"key":"514_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10067-006-0244-z","volume":"26","author":"Y Ozkan","year":"2007","unstructured":"Ozkan Y, Yard\u00fdm-Akayd\u00fdn S, Sepici A et al (2007) Oxidative status in rheumatoid arthritis. Clin Rheumatol 26:64\u201368. \n                    https:\/\/doi.org\/10.1007\/s10067-006-0244-z","journal-title":"Clin Rheumatol"},{"key":"514_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.bjp.0705054","volume":"138","author":"DC Phillips","year":"2003","unstructured":"Phillips DC, Woollard KJ, Griffiths HR (2003) The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol 138:501\u2013511. \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0705054","journal-title":"Br J Pharmacol"},{"key":"514_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0002-9440(10)63109-4","volume":"164","author":"T Pufe","year":"2004","unstructured":"Pufe T, Lemke A, Kurz B et al (2004) Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 164:185\u2013192. \n                    https:\/\/doi.org\/10.1016\/S0002-9440(10)63109-4","journal-title":"Am J Pathol"},{"key":"514_CR34","doi-asserted-by":"publisher","first-page":"6097417","DOI":"10.1155\/2016\/6097417","volume":"2016","author":"CM Qui\u00f1onez-Flores","year":"2016","unstructured":"Qui\u00f1onez-Flores CM, Gonz\u00e1lez-Ch\u00e1vez SA, Del R\u00edo N\u00e1jera D, Pacheco-Tena C (2016) Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: a systematic review. Biomed Res Int 2016:6097417. \n                    https:\/\/doi.org\/10.1155\/2016\/6097417","journal-title":"Biomed Res Int"},{"key":"514_CR35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.intimp.2004.11.013","volume":"5","author":"SVB Reddy","year":"2005","unstructured":"Reddy SVB, Wanchu A, Khullar M et al (2005) Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis. Int Immunopharmacol 5:1085\u20131090. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2004.11.013","journal-title":"Int Immunopharmacol"},{"key":"514_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","volume":"183","author":"P Ruiz-Lim\u00f3n","year":"2017","unstructured":"Ruiz-Lim\u00f3n P, Ortega R, Arias de la Rosa I et al (2017) Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. Transl Res 183:87\u2013103. \n                    https:\/\/doi.org\/10.1016\/j.trsl.2016.12.003","journal-title":"Transl Res"},{"key":"514_CR37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/art.1780290411","volume":"29","author":"J Schalkwijk","year":"1986","unstructured":"Schalkwijk J, van der Berg W, van de Putte L, Joosten L (1986) An experimental model for hydrogen peroxide\u2013induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues. Arthritis Rheum 29:532\u2013538. \n                    https:\/\/doi.org\/10.1002\/art.1780290411","journal-title":"Arthritis Rheum"},{"key":"514_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clinbiochem.2014.08.016","volume":"48","author":"S Shahmohamadnejad","year":"2015","unstructured":"Shahmohamadnejad S, Vaisi-Raygani A, Shakiba Y et al (2015) Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary. Clin Biochem 48:63\u201369. \n                    https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.08.016","journal-title":"Clin Biochem"},{"key":"514_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","volume":"4","author":"H Sies","year":"2015","unstructured":"Sies H (2015) Oxidative stress: a concept in redox biology and medicine. Redox Biol 4:180\u2013183. \n                    https:\/\/doi.org\/10.1016\/j.redox.2015.01.002","journal-title":"Redox Biol"},{"key":"514_CR40","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/art.30457.Increased","volume":"63","author":"C Spurlock III","year":"2011","unstructured":"Spurlock C III, Aune ZT, Tossberg JT et al (2011) Increased sensitivity to apoptosis induced by methotrexate is mediated by Jun N-terminal kinase. Arthritis Rheum 63:2606\u20132616. \n                    https:\/\/doi.org\/10.1002\/art.30457.Increased","journal-title":"Arthritis Rheum"},{"key":"514_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00296-001-0163-x","volume":"21","author":"S Taysi","year":"2002","unstructured":"Taysi S, Polat F, Gul M et al (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200\u2013204. \n                    https:\/\/doi.org\/10.1007\/s00296-001-0163-x","journal-title":"Rheumatol Int"},{"key":"514_CR42","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1185\/030079907X187955","volume":"23","author":"I T\u00fanez","year":"2007","unstructured":"T\u00fanez I, Feij\u00f3o M, Huerta G et al (2007) The effect of infliximab on oxidative stress in chronic inflammatory joint disease. Curr Med Res Opin 23:1259\u20131267. \n                    https:\/\/doi.org\/10.1185\/030079907X187955","journal-title":"Curr Med Res Opin"},{"key":"514_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt ME, Keystone EC, Furst DE et al (2003) Adalimumab, a fully human anti-tumor necrosis factor \u03b1 monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48:35\u201345. \n                    https:\/\/doi.org\/10.1002\/art.10697","journal-title":"Arthritis Rheum"},{"key":"514_CR44","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/ard.2010.132720","volume":"70","author":"CJ Wruck","year":"2011","unstructured":"Wruck CJ, Fragoulis A, Gurzynski A et al (2011) Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 70:844\u2013850. \n                    https:\/\/doi.org\/10.1136\/ard.2010.132720","journal-title":"Ann Rheum Dis"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-018-0514-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0514-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0514-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T19:18:54Z","timestamp":1564427934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-018-0514-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1007\/s10787-018-0514-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they do not have any conflict of interest and that they have full control of all primary data and that they agree to allow the journal to review their data if requested.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}